Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.

Study of forced degradation behavior of pramlintide acetate by HPLC and LC-MS.

Journal: Journal of food and drug analysis
Published: November 18, 2016

Preptin analogues: chemical synthesis, secondary structure and biological studies.

Preptin analogues: chemical synthesis, secondary structure and biological studies.

Journal: Chemical biology & drug design
Published: March 14, 2013

[D-Leu-4]-OB3, an orally bioavailable leptin-related synthetic peptide insulin sensitizer: a study comparing the efficacies of [D-Leu-4]-OB3 and metformin on energy balance and glycemic regulation in insulin-deficient male Swiss Webster mice.

[D-Leu-4]-OB3, an orally bioavailable leptin-related synthetic peptide insulin sensitizer: a study comparing the efficacies of [D-Leu-4]-OB3 and metformin on energy balance and glycemic regulation in insulin-deficient male Swiss Webster mice.

Journal: Peptides
Published: February 12, 2013

[D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.

[D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.

Journal: Regulatory peptides
Published: February 14, 2012

The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis.

The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis.

Journal: Diabetes, obesity & metabolism
Published: January 05, 2011

Gateways to clinical trials.

Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology
Published: May 21, 2009

Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications.

Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications.

Journal: Archives of neurology
Published: March 11, 2009

Gateways to clinical trials.

Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology
Published: January 15, 2008

Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.

Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.

Journal: Clinical therapeutics
Published: February 20, 2007

Pramlintide acetate in the treatment of Type 2 and Type 1 diabetes mellitus.

Pramlintide acetate in the treatment of Type 2 and Type 1 diabetes mellitus.

Journal: Expert review of endocrinology & metabolism
Published: January 01, 2007

Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.

Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.

Journal: Pharmacotherapy
Published: October 27, 2006

Gateways to clinical trials.

Gateways to clinical trials.

Journal: Methods and findings in experimental and clinical pharmacology
Published: April 26, 2006
Showing 1-12 of 34

Last Updated: 10/31/2025